In echoing this finding, we detected PDK1 expression in prostate cancer patients, and observed that samples of SPOP mutants displayed a relative higher PDK1 expression compared with that of samples harboring intact SPOP (Fig. 2I-J). This evidence concerns the gene SPOP and prostate carcinoma.